Bubble Intelligence

Market Intelligence For The New Regime

INSULET CORP
PODD
Latest Filing: May 6, 2026 • 25 Total Filings
Total Assets
2026
$2.99B
Total Revenue
2026
$761.70M
Net Income
2026
$91.10M
Operating Cash Flow
2026
$113.80M
Filing Year:
2025
Only 2025 data available
Data Source:
Showing data from all document types
Filters:
located inlocated inlocated inlocated inlocated incompetes withcompetes withcompetes withcompetes withcompetes withcompetes with
INSULET CORP
Ticker: PODD
Unknown Region
5 suppliers
Abbott
unknown
Abbott Diabetes Care, Inc.
component_supplier
Glooko Inc.
unknown
Dexcom
unknown
Dexcom, Inc.
component_supplier
Medtronic plc
Glucose monitoring devices, CGM systems, insulin pumps integrated with CGM
Major Competitor
Dexcom, Inc.
Tandem Diabetes Care Inc.
Insulin pump market
Major Competitor
Beta Bionics Inc.
Insulin pump market
Emerging
Abbott
CGM systems market
Major Competitor
Also a Supplier
Dexcom
Insulin delivery market
Also a Supplier
React Flow
Legend:
Company
Critical Supplier
Significant Supplier
Standard Supplier
Major Competitor
Emerging Competitor
Competitor
Regional Supplier Concentration
0 regions with known supplier geography · 5 suppliers without location data
Risk:LowModerateElevatedHigh
5 suppliers · no geography